An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study
<strong>Objectives</strong> To determine whether the introduction of the capsular group B meningococcal vaccine (4CMenB) in the United Kingdom has increased presentations of infants to Emergency Departments with Adverse Events Following Immunisation (AEFI) <strong>Participants, des...
Auteurs principaux: | Nainani, V, Galal, U, Buttery, J, Snape, M |
---|---|
Format: | Journal article |
Publié: |
BMJ Publishing Group
2017
|
Documents similaires
-
Meningococcal meningitis presenting postinfant group B meningococcal immunisation
par: So, N, et autres
Publié: (2018) -
Genomic surveillance and meningococcal group B vaccine coverage estimates after introduction of the vaccine into the national immunisation programme in the UK
par: Rodrigues, C, et autres
Publié: (2017) -
No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply
par: Snape, MD, et autres
Publié: (2006) -
Post‐vaccination healthcare attendance rate as a proxy measure for syndromic surveillance of adverse events following immunisation
par: Yonatan Moges Mesfin, et autres
Publié: (2021-04-01) -
Emerging clinical experience with vaccines against group B meningococcal disease
par: Wilkins, A, et autres
Publié: (2017)